Innovations in prenatal genetic testing beyond the fetal karyotype

Nursing Outlook

Volumn 62, Issue 3, 2014, Pages 212-218

  Founds, Sandra ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Next generation sequencing; Noninvasive prenatal diagnosis; Noninvasive prenatal testing; Whole genome sequencing

Indexed keywords

EDUCATION; FEMALE; GENETIC SCREENING; HEALTH CARE POLICY; HUMAN; MEDICAL GENETICS; NURSING; NURSING PROCESS; ORGANIZATION AND MANAGEMENT; PREGNANCY; PRENATAL DIAGNOSIS;

FEMALE; GENETIC TESTING; GENETICS, MEDICAL; HEALTH POLICY; HUMANS; NURSING PROCESS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84900026422     PISSN: 00296554     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.outlook.2013.12.010     Document Type: Article

References (55)

1. American Association of Colleges of Nursing. (2006). The essentialsof doctoral education for advanced nursing practice. Retrieved from. http://www.aacn.nche.edu/publications/position/DNPEssentials.pdf.
2. American Association of Colleges of Nursing. (2008). The essentials of baccalaureate education for professional nursing practice. Retrieved from. http://www.aacn.nche.edu/education-resources/BaccEssentials08.pdf.
3. American Association of Colleges of Nursing. (2009). Essential nursing competencies and curricular guidelines for genetics and genomics. Retrieved from. http://www.aacn.nche.edu/educationresources/Genetics__Genomics_Nursing_Competencies_09-22-06.pdf.
4. American Association of Colleges of Nursing. (2011). The essentialsof master's education in nursing. Retrieved from. http://www.aacn.nche.edu/education-resources/MastersEssentials11.pdf.
5. American Association of Colleges of Nursing. (2012). Essential genetic and genomic competencies for nurses with graduate degrees. Retrieved from. http://www.genome.gov/Pages/Health/HealthCareProvidersInfo/Grad_Gen_Comp.pdf.
6. American College of Obstetricians and Gynecologists ACOG technical bulletin: Preconceptional care. Number 205. International Journal of Gynecology & Obstetrics 1995, 50(2):201-207.
7. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 77: Screening for fetal chromosomal abnormalities. ACOG Committee on Practice Bulletins. Obstetetrics & Gynecology 2007, 109(1):217-227.
8. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 446: Array comparative genomic hybridization in prenatal diagnosis. Obstetetrics & Gynecology 2009, 114(5):1161-1163.
9. American College of Obstetricians and Gynecologists. ACOG Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstetetrics & Gynecology 2012, 120(6):1532-1534.
10. American Academy of Nursing. (2008). Comments on the Secretary's Advisory Committee on Genetics, Health and Society Report U.S. System of oversight of genetic testing: A response to the charge of theSecretary of HHS. Retrieved from. http://www.aannet.org/ep-genetic%13health-care.
11. American Academy of Nursing Women's Health Expert Panel. (2012). Call to action: Put prevention into women's health practice. Retrieved from. http://www.aannet.org/assets/docs/PolicyResources/wh%20prevention%20into%20practice%20call%20to%20action%206%2012f.pdf.
12. American Academy of Nursing Expert Panels. (2013). Retrieved from. http://www.aannet.org/expert-panels.
13. American College of Nurse Midwives. Share with women: Prenatal tests for Down Syndrome. Journal of Midwifery and Women's Health 2005, 50(3):255-256.
14. American Nurses Association. (2007). Genetics/genomics nursing: Scope and standards of practice. Silver Spring, MD. Retrieved from. http://www.nursingworld.org/MainMenuCategories/EthicsStandards/Genetics-1/Genetics-and-Genomics-Nursing-Scope-and-Standards.pdf.
15. American Nurses Association Nursing: Scope and standards of practice 2010, ANA, Silver Spring, MD. 2nd ed.
16. American Nurses Association. (2013). NursingWorld. Retrieved from. http://www.nursingworld.org/.
17. Association of Women's Health, Obstetric and Neonatal Nurses. (2000). Role of the registered nurse in support of patients as related to genetic testing. Retrieved from. http://www.awhonn.org/.../Documents/pdf/5_Genetic.pdf.
18. Bianchi D.W. From prenatal genomic diagnosis to fetal personalized medicine: Progress and challenges. Natural Medicine 2012, 18(7):1041-1051.
19. Borry P., Henneman L., Lakeman P., ten Kate L.P., Cornel M.C., Howard H.C. Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Human Reproduction 2011, 26(5):972-977.
20. Brady P.D., Devriendt K., Deprest J., Vermeesch J.R. Array-based approaches in prenatal diagnosis. Methods in Molecular Biology 2012, 838:151-171.
21. Breman A., Patel A. Preparation of chorionic villus samples for metaphase chromosome analysis and chromosomal microarray analysis. Current Protocols in Human Genetics 2012, Chapter 8:8.3.1-8.3.9.
22. Centers for Disease Control and Prevention Update on overall prevalence of major birth defects: Atlanta, Georgia, 1978-2005. Morbidity and Mortality Weekly Report 2008, 57(01):1-5.
23. Centers for Disease Control and Prevention. (2013a). Unintended pregnancy prevention. Retrieved from. http://www.cdc.gov/reproductivehealth/UnintendedPregnancy/index.htm.
24. Centers for Disease Control and Prevention. (2013b). National Center on Birth Defects and Developmental Disabilities. Retrieved from. http://www.cdc.gov/ncbddd/index.html.
25. Crawford D.C., Dilks H.H. Strategies for genotyping. Current Protocols in Human Genetics 2011, Chapter 1:1.3.1-1.3.22.
26. 45 CFR 160 and 164 modifications to the HIPAA Privacy, Pecurity, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules. Federal Register 2013, 78(17). Department of Health and Human Services, Retrieved from. http://www.gpo.gov/fdsys/pkg/FR-2013-01-25/pdf/2013-01073.pdf.
27. Donley G., Hull S.C., Berkman B.E. Prenatal whole genome sequencing: Just because we can, should we?. The Hastings Center Report 2012, 42(4):28-40.
28. Founds S.A., Dorman J.S., Conley Y.P. Microarray technology applied to the complex disorder of preeclampsia. Journal of Obstetric, Gynecologic, and Neonatal Nursing 2008, 37(2):146-157.
29. Goldsmith L., Jackson L., O'Connor A., Skirton H. Direct-to-consumer genomic testing: Systematic review of the literature on user perspectives. European Journal of Human Genetics 2012, 20(8):811-816.
30. Goldsmith L., Jackson L., O'Connor A., Skirton H. Direct-to-consumer genomic testing from the perspective of the health professional: A systematic review of the literature. Journal of Community Genetics 2013, 4(2):169-180.
31. Hook E.B., Cross P.K., Schreinemachers D.M. Chromosomal abnormality rates at amniocentesis and in live-born infants. Journal of American Medical Association 1983, 249(15):2034-2038.
32. Johnson K., Posner S.F., Biermann J., Cordero J.F., Atrash H.K., Parker C.S., Curtis M.G. Recommendations to improve preconception health and health care-United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recommendations Report 2006, 55(RR-6):1-23.
33. Kitzman J.O., Snyder M.W., Ventura M., Lewis A.P., Qiu R., Simmons L.E., Shendure J. Noninvasive whole-genome sequencing of a human fetus. Science Translational Medicine 2012, 4(137):137ra76.
34. Lewis J.A. Genetics and genomics: Impact on perinatal nursing. Journal of Perinatal and Neonatal Nursing 2011, 25(2):144-147.
35. Levy B., Jobanputra V., Warburton D. Preparation and culture of products of conception and other solid tissues for chromosome analysis. Current Protocols in Human Genetics 2009, Chapter 8:8.5.1-8.5.11.
36. Mathews, T. J., & MacDorman, M. F. (2012). Infant mortality statistics from the 2008 period Linked Birth/Infant Death Data Set. Retrieved from. http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_05.pdf.
37. March of Dimes. (2013). Preconception and prenatal genetic screening pocket facts. Retrieved from. https://www.marchofdimes.com/catalog/product.aspx?productid=5039%26categoryid=155%26productcode=31-2595-12.
38. Miller, D. T. (2013). Use of array comparative genomic hybridization (aCGH) in obstetrics. UpToDate. Retrieved from. http://www.uptodate.com/home.
39. National Human Genome Research Institute. (2012). Family Medical History and Tools Resources Online. Retrieved from. http://www.genome.gov/11510372.
40. National Human Genome Research Institute. (2013). Regulation ofgenetic tests. Retrieved from. http://www.genome.gov/10002335.
41. Newberger D.S. Down syndrome: Prenatal risk assessment and diagnosis. American Family Physician 2000, 62(4):825-832. 837-838.
42. Nygren A.O., Dean J., Jensen T.J., Kruse S., Kwong W., van den Boom D., Ehrich M. Quantification of fetal DNA by use of methylation-based DNA discrimination. Clinical Chemistry 2010, 56(10):1627-1635.
43. Olney R.S., Moore C.A., Khoury M.J., Erickson J.D., Edmonds L.D., Botto L.D. Chorionic villus sampling and amniocentesis: Recommendations for prenatal counseling. Morbidity and Mortality Weekly Report 1995, 44(RR-9):1-12.
44. Parker S.E., Mai C.T., Canfield M.A., Rickard R., Wang Y., Meyer R.E. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Research Part A: Clinical and Molecular Teratology 2010, 88(12):1008-1016. National Birth Defects Prevention Network.
45. Public Law 110-374 (2008). Prenatally and Postnatally Diagnosed Conditions Awareness Act. 42 USC 280g-8; 122 STAT 4051. Retrieved from. http://www.govtrack.us/congress/bills/110/s1810.
46. Public Law 111-148 (2010). Patient Protection and Affordable Care Act. Retrieved from. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/content-detail.html.
47. Ram K.T., Klugman S.D. Best practices: Antenatal screening for common genetic conditions other than aneuploidy. Current Opinion in Obstetrics and Gynecology 2010, 22(2):139-145.
48. Reilly P.R. Commentary: The federal 'Prenatally and Postnatally Diagnosed Conditions Awareness Act'. Prenatal Diagnosis 2009, 29(9):829-832.
49. Sackey, J. A. (2013). Preconception evaluation and counseling. UpToDate. Retrieved from. http://www.uptodate.com/home.
50. Sarata, A. K., DeBergh, J. V., & Staman, J. (2011). The Genetic Information Nondiscrimination Act of 2008 and the Patient Protection and Affordable Care Act of 2010: Overview and Legal Analysis of Potential Interactions. Congressional Research Service. Retrieved from. http://www.genome.gov/Pages/PolicyEthics/GeneticDiscrimination/CRS_GINA_and_ACA.pdf.
51. Skirton H., Patch C. Factors affecting the clinical use of noninvasive prenatal testing: A mixed methods systematic review. Prenatal Diagnosis 2013, 33(6):532-541.
52. Skirton H., Jackson L., Goldsmith L., O'Connor A. Are health professionals ready for direct-to-consumer genetic and genomic testing?. Personalized Medicine 2013, 10(7):673-682.
53. Tabor A., Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagnosis and Therapy 2010, 27(1):1-7.
54. Tucker T., Marra M., Friedman J.M. Massively parallel sequencing: the next big thing in genetic medicine. American Journal of Human Genetics 2009, 85(2):142-154.
55. Wapner R.J., Martin C.L., Levy B., Ballif B.C., Eng C.M., Zachary J.M., Jackson L. Chromosomal microarray versus karyotyping for prenatal diagnosis. New England Journal of Medicine 2012, 367(23):2175-2184.